Table 1.
Clinical Characteristics | (%) | Total number | ||
---|---|---|---|---|
Gender | 99 (100%) | |||
Male | 52 | 52.5 | ||
Female | 47 | 47.5 | ||
Age (years) | 99 (100%) | |||
Mean | 16 | |||
Median | 12 | |||
Max. | 72 | |||
Min. | 0.08 | |||
Age group | 99 (100%) | |||
Adult | 37 | 37.4 | ||
Pediatric | 62 | 62.6 | ||
Tumor site | 99 (100%) | |||
PM | 64 | 64.6 | ||
S | 25 | 25.3 | ||
O | 10 | 10.1 | ||
Histopathology | 99 (100%) | |||
ERMS | 33 | 33.3 | ||
ARMS | 53 | 53.5 | ||
SRMS-ScRMS | 13 | 13.1 | ||
Tumor size | 68 (69%) | |||
Mean | 4.3 | |||
Median | 4.0 | |||
Max. | 12 | |||
Min. | 0.8 | |||
Regional lymph node | 97 (98%) | |||
Positive | 40 | 40.8 | ||
Negative | 57 | 58.2 | ||
Initial metastasis | 99 (100%) | |||
Positive | 19 | 19.2 | ||
Negative | 80 | 80.8 | ||
Stage | 99 (100%) | |||
1 | 29 | 29.3 | ||
2 | 10 | 10.1 | ||
3 | 41 | 41.4 | ||
4 | 19 | 19.2 | ||
Recurrence | 97 (98%) | |||
Local | 9 | 9.3 | ||
Distant | 8 | 8.2 | ||
Local & distant | 5 | 5.2 | ||
None | 75 | 77.3 | ||
Vital status | 97 (98%) | |||
Alive | 69 | 71.1 | ||
Deceased | 28 | 28.9 | ||
Follow-up duration (months) | 97 (98%) | |||
Mean | 83.6 | |||
Median | 65 | |||
Max. | 232 | |||
Min. | 4 |